Professor Angelo Corti, Director of the Experimental Oncology division of the SRSI, discusses approaches to oncology research and the institute´s significant contribution to the field in Italy.
What is the philosophy of the SRSI’s oncology division towards oncology research?
The development of new strategies to improve cancer prevention, detection and treatment remains a primary aim for cancer research. This requires significant investments in basic, as well as in translational and clinical research. The investment in basic research is aimed at understanding the molecular and cellular mechanisms underlying this disease, whereas the investment in translational and clinical research is aimed at translating the basic knowledge into the development of new diagnostic or prognostic tools and therapeutic agents.
"Cancer is not one disease; rather it is a collection of many different diseases that require specific diagnostic and therapeutic tools, specialized researchers and physicians."
